🇺🇸 FDA
Patent

US 11560372

Heterocyclic compounds useful as modulators of acetylcholine receptors

granted A61PA61P1/00A61P1/10

Quick answer

US patent 11560372 (Heterocyclic compounds useful as modulators of acetylcholine receptors) held by Takeda Pharmaceutical Company Limited expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P1/00, A61P1/10